Psychological response of patients receiving two drug regimen for lung carcinoma

Silberfarb, Peter M; Holland, Jimmie C. B; Anbar, Daniel; Bahna, Geraldine; Maurer, Herbert; Chahinian, A. Philippe; Comis, Robert.
American Journal of Psychiatry ; 140(1): 110-1, 1983.
Artículo en Inglés | Bivipsil | ID: psa-119040

Documentos relacionados

  1. The biochemistry of disease: desperately seeking syzygy.
  2. Validation of a computerized decision support system to review pharmacotherapy treatment: scheduling guidelines.
  3. Aortite chez une patiente recevant une chimiothérapie.
  4. Evaluating automated entity extraction with respect to drug and non-drug treatment strategies.
  5. [Dissonance in addictology - The missed encounter between Laszlo Levendel and Thomas Szasz].
  6. Prediction of drug's Anatomical Therapeutic Chemical (ATC) code by integrating drug-domain network.
  7. [Health-Related Quality of Life in the Context of Early Benefit Assessment of Drugs According to § 35a of the German Social Code Book V: A Challenging Endpoint for all the Involved Stakeholders].
  8. Communication in Drug Development: "Translating" Scientific Discovery.
  9. RNA-based therapeutics: ready for delivery?
  10. Fatigue in patients on oral targeted or chemotherapy for cancer and associations with anxiety, depression, and quality of life.